Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028948 · ClinicalTrials.gov registry record · NA
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
A NA study of Stage IIIA Skin Melanoma and Stage 0 Skin Melanoma, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 485
- Enrollment target
- 2
- Study locations
NCT03028948 is a NA study of Stage IIIA Skin Melanoma and Stage 0 Skin Melanoma that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 485 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03028948, a NA study of Stage IIIA Skin Melanoma and Stage 0 Skin Melanoma, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 485 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial studies how well an interactive tailored website works in promoting sun protection and skin self-check behaviors in patients with stage 0-III melanoma. An internet-based program may help individuals to perform skin self-checks and engage in sun protection behaviors.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Questionnaire Administration
- OTHER Internet-Based Intervention
Study Locations (2)
New Jersey
- Rutgers Cancer Institute of New Jersey - New Brunswick
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 485 participants |
| Start Date | 2017-01-13 |
| Est. Completion | 2020-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03028948
The ClinicalTrials.gov registry entry for NCT03028948 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 485 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Stage IIIA Skin Melanoma appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT03028948 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Virginia.
Frequently Asked Questions
What is clinical trial NCT03028948 about?
NCT03028948 is a clinical study titled "Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma". This clinical trial studies how well an interactive tailored website works in promoting sun protection and skin self-check behaviors in patients with stage 0-III melanoma. An internet-based program may help individuals to perform skin self-checks and engage in sun protection behaviors.
What is the current status of trial NCT03028948?
This trial is currently completed. It is a NA study. The enrollment target is 485 participants. The study started on 2017-01-13. Estimated completion is 2020-08-29.
What conditions does trial NCT03028948 study?
This clinical trial studies the following conditions: Stage IIIA Skin Melanoma, Stage 0 Skin Melanoma, Stage I Skin Melanoma, Stage IA Skin Melanoma, Stage IB Skin Melanoma.
What interventions are being tested in trial NCT03028948?
The interventions under investigation include: Survey Administration (OTHER), Questionnaire Administration (OTHER), Internet-Based Intervention (OTHER).
Who is sponsoring clinical trial NCT03028948?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03028948 being conducted?
This trial has 2 study locations across New Jersey, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IIIA Skin Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy
ACTIVE NOT RECRUITING · Phase 2
-
Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.